Rocco Maurizio Zagari, MD, Graham Richard Law, PhD, Lorenzo Fuccio, MD, Paolo Pozzato, MD, David Forman, Phd and Franco Bazzoli, MD.

Slides:



Advertisements
Similar presentations
Practice Guidelines & clinical pathway on management of Dyspepsia
Advertisements

A 50-year-old man with a history of symptomatic gastroesophageal reflux disease (GERD) has Barrett’s esophagus diagnosed on upper endoscopy. Which of.
Nursing Care of Patients WithUpper GI Disturbances
BACKGROUND & AIM THE IMPACT OF GERD ON EXACERBATIONS OF COPD HAS NEVER BEEN EVALUATED. TO DETERMINE THE PREVALENSI OF GER SYMPTOMS IN COPD PATIENTS.
What is dyspepsia? A non-specific group of symptoms that relate to the upper GI tract: Epigastric pain Feelings of bloating or fullness Heartburn Rome.
Management of Patients With Gastric and Duodenal Disorders
Ferrara 27 Settembre 2014 Camera di Commercio, Largo Castello
Peptic ulcer disease.
DYSPEPSIA Dr.Vishal Rathore. Dyspepsia popularly known as indigestion meaning hard or difficult digestion, is a medical condition characterized by chronic.
Functional dyspepsia Ermias D. (MD). Diagnosis Functional, idiopathic, non ulcer Rome III criteria –Bothersome post prandial fullness –Early satiety –Epigastric.
PEPTIC ULCER DISEASE. I. Definition A. Breakdown of the mucosa of the UGI tract-non malignant 1. Lack of depth-erosion B. Imbalance between acidity (pH)
DYSPEPSIA Leena Patel 1/2/12. OVERVIEW Statistics Red flags Management H-pylori testing and treatment.
WILLIAM J. SALYERS, JR., MD, MPH DIVISION CHIEF/MEDICAL DIRECTOR KU WICHITA GASTROENTEROLOGY ASSOCIATE PROGRAM DIRECTOR INTERNAL MEDICINE RESIDENCY Putting.
PEPTIC ULCER DISEASE NRS452 Norhaini Majid.
PUD & GORD Nik Sanyal. Overview How common is it + what are the risk factors? What are the symptoms and signs? Investigations Management Possible exam.
An approach to dyspeptic patients
Peptic Ulcer Disease. Peptic ulcer  refers to erosion of the mucosa lining any portion of the G.I. tract.  It is defined as : A circumscribed ulceration.
Stomach Ulcer(Peptic Ulcer) Stomach ulcer or peptic ulcer is the damage of the protective layer (lining) of stomach or gastrointestinal tract It may be.
High Value Care: GERD Sheetal Sharma, MBBS Assistant Professor of Clinical Medicine Associate Director of Endoscopic Quality Section of Advanced Therapeutic.
CHAPTER 24 Indications and Outcomes of Gastrointestinal Endoscopy Source: Burden of digestive diseases in the United States, NIH Publication No.
Prevalence of Helicobacter pylori infection in chronic dyspeptic patients with peptic ulcer in Naresuan University Hospital Researchers Rutnumnoi Thanachat.
GASTRIC LYMPHOMAS Aswad H. Al.Obeidy FICMS, FICMS GE&Hep Kirkuk General Hospital.
SIGNIFICANT EVENT MEETING – 2 PATIENTS WITH CANCER – 2 PATIENTS WITH CANCER Dr Stephen Newell 8/10/04.
What are we talking about? Functional gastrointestinal disorders (FGIDs) are defined as a variable combination of chronic or recurrent gastrointestinal.
PUD Peptic Ulcer Disease Prince Sattam Bin AbdulAziz University College Of Pharmacy Mohammad Ruhal Ain R Ph, PGDPRA, M Pharm (Clin. Pharm) Department of.
Dyspepsia MAHSA KHODADOOSTAN-- GASTROENTROLOGIST.
Primary Care Management of Dyspepsia Policy Context Richard Stevens MA FRCGP General Practitioner, Oxford Chairman, Primary Care Society for Gastroenterology.
Dyspepsia Summary of the Today Session.
Peptic Ulcer Disease Dr. Wael H. Mansy, MD Assistant Professor College of Pharmacy King Saud University.
NICE guidelines: Management of dyspepsia in adults in primary care
JOURNAL REVIEW Questionnaire study and audit of use of ACEI and monitoring in general practice BMJ 1999;318:
Coordinator: Dr. Anca Negovan Author: Andreea Bianca Stoica Co-authors: Drd. Monica Pantea Adrian Stoica Roxana Spac Gavriela Radoiu.
Upper Gastrointestinal Diseases. Upper GI Diseases Esophagus Stomach Duodenum.
The ulcer of gastric stump: a case-control study Coordinators: Author: Roxana Spac Dr.Anca Negovan Drd. Monica Pantea Co-author: Dr Nina Sincu Andreea.
Clinical features of Upper GI origin More than 4 weeks duration Pain induced or worsened by food 40% of adults have in a life time Generally benign – promote.
Gastrointestinal Diseases Dr. Maha Arafah Pathology, 2012.
Dyspepsia Resident Teaching Rounds Steve Radke August 11, 2003 References: Ontario Program for Optimal Therapeutics, Ontario Guidelines for PUD and GERD.
Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Question.
Indigestion.
Approch to dyspepsia Vossoughinia H Associate professor of medicine Mashad university of medical sceinces.
Peptic ulcers are open sores in the mucosa of the lower oesophagus (esophageal ulcer), duodenum (dudenal ulcer ) and stomach (gastric ulcers). Caused.
 In 2014, NSAIDs were prescribed more than 100 million times per year in USA.  29 million adults (12.1%) were regular NSAIDs user in USA. 2.
Case A 48 year old man presented with post prandial epigastric pain for 6 months. Omeprazole 20 mg/D is effective in relieving pain but pain recurs when.
소화기내과 R1. 임형석 / Pf. 김정욱. BACKGROUND Recent data showed that H. pylori infection is less common in patients with IBD The prevalence of IBD has been increasing.
Predicting Mortality in Non-Variceal Upper Gastrointestinal Bleeders: Validation of the Italian PNED Score and Prospective Comparison With the Rockall.
Peptic Ulcer Bleeding Risk. The Role of Helicobacter Pylori Infection in NSAID/Low-Dose Aspirin Users C. Sostres, MD, P. Carrera-Lasfuentes, PhD, R. Benito,
Famotidine Is Inferior to Pantoprazole in Preventing Recurrence of Aspirin-Related Peptic Ulcers or Erosions FOOK–HONG NG, SIU–YIN WONG, KWOK–FAI LAM,
Dyspepsia. one or more of the following symptoms Postprandial fullness, early satiation, epigastric pain, or burning.
R4 박 철 기 Endoscopy 2010; 42: 109–113. Introduction  Sodium phosphate (NaP – Fleet) Osmotic laxative – increase colonic water content by extracellular.
Clinical Practice Helicobacter pylori Infection Kenneth E.L. McColl, M.D. N Engl J Med Volume 362(17): April 29, 2010.
GI For Rehabilitation.
FUNCTIONAL (NON-ULCER) DYSPEPSIA TUCOM Internal Medicine 4th class Dr
Fatimah Abdullah 6th year MS, KFU
PROTON PUMP INHIBITORS (PPI)
The Prevalence of and Risk Factors for Barrett Esophagus in a Korean Population - A Nationwide Multicenter Prospective Study - J Clin Gastroenterol 2009.
DYSPEPSIA Dr.Azam teimouri Gastroenterologist
Gastritis.
Presenting problems in gastrointestinal disease
Qassim J. odda Master in adult nursing
Upper gastrointestinal surgical diseases.
Gastroesophageal reflux disease
Volume 114, Issue 3, Pages (March 1998)
Volume 114, Issue 3, Pages (March 1998)
Nutrition management for peptic ulcer
Nonulcer Dyspepsia: A Look Into the Future
Gastrointestinal Pathology I
Peptic Ulcer Disease Candice W. Laney Spring 2014.
Presentation transcript:

Rocco Maurizio Zagari, MD, Graham Richard Law, PhD, Lorenzo Fuccio, MD, Paolo Pozzato, MD, David Forman, Phd and Franco Bazzoli, MD.

INTRODUCTION  Chronic and recurrent dyspeptic symptoms Common symptoms in general population  Epigastric pain, postprandial fullness, early satiety, etc. Endoscopycally negative condition: functional dyspepsia Endoscopycally organic lesions: peptic ulcer, esophagitis Such lesion with asymptomatic conditions  Dyspeptic symptoms Less likely associated with esophagitis With prominent heartburn or regurgitation : associated with gastroesophageal reflux disease with or without esophagitis In primary care study, prevalence of peptic ulcer  With prominent reflux symptoms ≈ without symptoms

INTRODUCTION  Endoscopic findings and symptoms Unclear state Improve the management of patients with uninvestigated dyspepsia Sorreisa study in Norway  Asymptomatic peptic ulcers - quite common  Several potential methodological problems  Symptoms were not assessed using a validated questionnaire Kalixanda study in Sweden  Ulcer frequently show atypical symptoms  Provided only data on the association between dyspeptic symptoms and peptic ulcer

PURPOSES  In this study, General population in Italy The prevalence of endoscopic findings and their association with dyspeptic symptoms in the community

METHODS: Study population  MICOL Multicentre Italian Study on Cholelithiasis Loiano and Monghidoro near Bologna in Northern Italy Gave informed consent : UBT as part of an additional study of H. pylori infection.

METHODS: Assessments  Participants A validated dyspepsia questionnaire Upper gastrointestinal endoscopy 13 C-urea breath test Discontinuation of PPI, H2Rc antagonist, antibiotics at least 4wks  Gastrointestinal symptoms questionnaire Frequency and severity At least once a month for 3 months during the previous year Collected data on following symptoms

Definition Dyspeptic symptomsepigastric pain postprandial fullness or early satiety Reflux symptomsHeart burning Regurgitation Alarm symptomsDysphagia (Odynophagia) Alarm signsrecurrent vomiting Unexplained weight loss Sign of UGI bleeding : IDA, hematochezia, melena Frequent symptomOccurred at least 2 days/week Regardless of the severity Infrequent symptomOnce a week ~ once a month At least moderate severity METHODS: Assessments

 Upper gastrointestinal endoscopy Mucosal erythema of esophagus: excluded Esophagitis: Savary-Miller Classification Barrett’s esophagus diagnosed by biopsy Peptic ulcer : >3mm mucosal break Acute gastrointestinal erosions : <3mm mucosal break  H. pylori status Rapid urea test Histology 13 C-urea breath test H. pylori (+): two of these three were positive

Savary-Miller Classification Grade I Grade II Grade IIIGrade IV

METHODS: Statistical methods  Risk assessment Symptomatic subject compared with those asymptomatic Odds ratios(OR), 95% confidence intervals(CI)  Calculated after adjustment for sex, age, body mass index  H. pylori, alcohol, smoking, coffee  Medication: NSAID, aspirin, corticosteroids  Using in Stata (StataCorp Stata Statistical soft ware: Release 9. College station, TX: Stata Corp LP)

RESULTS: Symptoms

RESULTS: Endoscopic findings 38% 30% 36% 51% 21%

RESULTS: Endoscopic findings (OR 25.51%, 95%CI 4.62~140.98)

RESULTS: Endoscopic findings

CONCLUSION  Almost 3/4 of subjects with dyspeptic symptoms do not have endoscopic findings  Esophagitis may be the cause of dyspeptic symptoms in subjects with prominent reflux symptoms  Peptic ulcer may be the cause of dyspeptic symptoms in a subgroup of subjects with or without prominent reflux symptoms